glp gip glucagon & cagrilintide Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports nejm Semaglutide, a glucagon-like peptide-1

Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5)

Since 2012, Methyl-Life has been dedicated to providing evidence-based education to help individuals better understand methylation and nutritional wellness

The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and human

Nevertheless, if its senolytic action has been demonstrated in several diseases such as osteoarthritis 15,16 as well as in neurodegenerative diseases 17 , the effect of ABT-263 is restricted to senescent cells from specific cell types 18 , leading to the necessity to identify new potential senolytics to target senescent cells in age-related diseases